Article Information
- Received August 11, 2003
- Revision received September 22, 2003
- Accepted September 28, 2003
- First published November 26, 2003.
- Version of record published November 26, 2003.
Author Information
- Janet Alder1,*,
- Smita Thakker-Varia1,*,
- Debra A. Bangasser2,
- May Kuroiwa1,
- Mark R. Plummer3,
- Tracey J. Shors2, and
- Ira B. Black1
- 1Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854-5635, 2Department of Psychology and Center for Collaborative Neuroscience, and 3Faculty of Arts and Sciences Division of Life Sciences, Nelson Laboratories, Rutgers University, Piscataway, New Jersey 08854
Author contributions
Disclosures
- Received August 11, 2003.
- Revision received September 22, 2003.
- Accepted September 28, 2003.
This work was funded by grants from the National Institute of Child Health and Human Development, National Alliance for Research on Schizophrenia and Depression, The Foundation of University of Medicine and Dentistry of New Jersey, and the New Jersey Commission for Science and Technology. We are grateful to S. Salton for providing VGF peptides. We thank C. Donahue and K. Kosik for RNA from trained rats and M. Borrero for technical help with VGF immunocytochemistry and Western blots.
Correspondence should be addressed to Dr. Ira B. Black, Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 675 Hoes Lane, Center for Advanced Biotechnology and Medicine, Piscataway, NJ 08854-5635. E-mail: black{at}cabm.rutgers.edu.
Copyright © 2003 Society for Neuroscience 0270-6474/03/2310800-09$15.00/0
↵* J.A. and S.T.-V. contributed equally to this work.
Online Impact